title: Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over Study.
abstract: ♦
  
  
  OBJECTIVE
  In this study, we investigated, and this for the different classes of uremic toxins, whether increasing dialysate volume by shifting from continuous ambulatory peritoneal dialysis (CAPD) to higher volume automated peritoneal dialysis (APD) increases total solute clearance. ♦
  
  
  METHODS
  Patients on peritoneal dialysis were randomized in a cross-over design to one 24-hour session of first a CAPD regimen (3*2 L of Physioneal 1.36% and 1*2 L of icodextrin) or APD (consisting of 5 cycles of 2 L Physioneal 1.36 and 1 cycle of 2 L Extraneal), and the other week the alternate regime, each patient serving as his/her own control. Dialysate, blood and urine samples were collected and frozen for later batch analysis of concentrations of urea, creatinine, phosphorus, uric acid, hippuric acid, 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid, indoxyl sulfate, indole acetic acid, and p-cresyl sulfate. For the protein-bound solutes, total and free fractions were determined. Total, peritoneal and renal clearance (K) and mass removal (MR) of each solute were calculated, using validated models. ♦
  
  
  RESULTS
  In 15 patients (11 male, 3 diabetics, 56 ± 16 years, 8 on CAPD, time on peritoneal dialysis 12 ± 14 months, and residual renal function of 9.9 ± 5.4 mL/min) dialysate over plasma ratio for creatinine (D/Pcrea) was 0.62 ± 0.10. Drained volume and obtained ultrafiltration were higher with APD vs CAPD (13.3 ± 0.5 L vs 8.5 ± 0.7 L and 1.3 ± 0.5 L vs 0.5 ± 0.7 L), whereas urine output was lower (1.0 ± 0.5 L vs 1.4 ± 0.6 L). Total clearance and MR tended to be higher for CAPD vs APD for all small and water soluble solutes, but mainly because of higher renal contribution, with no difference in the peritoneal contribution. For the protein-bound solutes, no differences in clearance or mass removal were observed. ♦
  
  
  CONCLUSIONS
  Although the drained dialysate volume nearly doubled, APD did not result in better peritoneal clearance or solute removal vs classic CAPD. APD resulted in better ultrafiltration, but at the expense of residual urinary output and clearance.
authors.affiliation: Renal Division, Department of Internal Medicine, Ghent University Hospital, Gent, Belgium.
authors.forename: Sunny
authors.initials: S
authors.lastname: Eloot
authors.affiliation: Renal Division, Department of Internal Medicine, Ghent University Hospital, Gent, Belgium.
authors.forename: Raymond
authors.initials: R
authors.lastname: Vanholder
authors.affiliation: Renal Division, Department of Internal Medicine, Ghent University Hospital, Gent, Belgium.
authors.forename: Clement
authors.initials: C
authors.lastname: Dequidt
authors.affiliation: Renal Division, Department of Internal Medicine, Ghent University Hospital, Gent, Belgium wim.vanbiesen@ugent.be.
authors.forename: Wim
authors.initials: W
authors.lastname: Van Biesen
mesh_terms: D000328:Adult; D000368:Aged; D001331:Automation; D003404:Creatinine / Q000097:blood; D018592:Cross-Over Studies; D015314:Dialysis Solutions / Q000493:pharmacokinetics* / Q000494:pharmacology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods; D018570:Risk Assessment; D014118:Toxins, Biological / Q000493:pharmacokinetics*; D016896:Treatment Outcome; D014508:Urea / Q000097:blood; D014511:Uremia / Q000175:diagnosis / Q000628:therapy
chemical_list: D015314:Dialysis Solutions; D014118:Toxins, Biological; C026865:uremia middle molecule toxins; D014508:Urea; D003404:Creatinine
keywords: APD; CAPD; Uremic toxin; clearance; dwells; removal